LifeStance Health Group (LFST) Stock Price

LifeStance Health Group Price

NASDAQ·CLOSED
10.48USD-0.26 (-2.45 %)
Market closed

Revenue has compounded at 37.3% per year over the past 6 years to 1.42 B USD. LifeStance Health Group's net margin stands at 0.7%, up from -46.0% several years earlier. Analysts set a median price target of 8.67 USD, implying 17.3% below the current price. Of 17 analysts, 14 rate the stock a buy — an overall Buy consensus. The stock trades about 172% above its 52-week low.

LifeStance Health Group stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of LifeStance Health Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how LifeStance Health Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing LifeStance Health Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

LifeStance Health Group Stock Price History
DateLifeStance Health Group Price
7/31/202610.48 USD
7/30/202610.74 USD
7/29/202611.10 USD
7/27/202610.96 USD
7/23/202610.81 USD
7/22/202611.01 USD
7/21/202611.45 USD
7/20/202611.34 USD
7/17/202611.58 USD
7/16/202611.29 USD
7/15/202610.97 USD
7/14/202610.79 USD
7/13/202610.84 USD
7/10/202610.70 USD
7/9/202610.80 USD
7/8/202610.66 USD
7/7/202610.90 USD
7/6/202611.40 USD
7/2/202611.27 USD
7/1/202611.43 USD
6/30/202610.71 USD
6/29/202610.53 USD
6/26/202610.28 USD
6/25/20269.88 USD
6/24/20269.65 USD
6/23/20269.44 USD
6/22/20269.06 USD
6/18/20268.86 USD
6/17/20268.73 USD
6/16/20268.65 USD
6/15/20268.56 USD
6/12/20268.52 USD
6/11/20268.08 USD
6/10/20267.73 USD
6/9/20267.66 USD
6/8/20267.34 USD
6/5/20267.49 USD
6/4/20267.76 USD
6/3/20267.51 USD
6/2/20267.85 USD
6/1/20267.82 USD
5/29/20267.76 USD
5/28/20267.72 USD
5/27/20267.51 USD
5/26/20267.51 USD
5/22/20267.29 USD
5/21/20267.47 USD
5/20/20267.71 USD
5/19/20267.73 USD
5/18/20267.80 USD
5/15/20267.65 USD
5/14/20267.89 USD
5/13/20268.10 USD
5/12/20267.93 USD
5/11/20267.67 USD
5/8/20267.70 USD
5/7/20268.85 USD
5/6/20267.36 USD
5/5/20267.34 USD
5/4/20267.27 USD
5/1/20267.53 USD
4/30/20267.57 USD
4/29/20267.43 USD
4/28/20267.67 USD
4/27/20267.27 USD
4/24/20267.05 USD
4/22/20266.91 USD
4/21/20266.79 USD
4/20/20266.92 USD
4/17/20266.89 USD
4/16/20266.67 USD
4/15/20266.55 USD
4/14/20266.51 USD
4/13/20266.46 USD
4/10/20266.40 USD
4/9/20266.49 USD
4/8/20266.54 USD
4/7/20266.41 USD
4/6/20266.40 USD
4/2/20266.31 USD
4/1/20266.37 USD
3/31/20266.37 USD
3/30/20266.24 USD
3/27/20266.32 USD
3/26/20266.69 USD
3/25/20266.65 USD
3/24/20266.45 USD
3/23/20266.53 USD
3/20/20266.40 USD
3/19/20266.46 USD
3/18/20266.41 USD
3/17/20266.58 USD
3/16/20266.45 USD
3/13/20266.33 USD
3/12/20266.33 USD
3/11/20266.64 USD
3/10/20266.73 USD
3/9/20266.91 USD
3/6/20266.93 USD
3/5/20266.95 USD
3/4/20267.33 USD
3/3/20267.27 USD
3/2/20267.14 USD
2/27/20267.24 USD
2/26/20266.96 USD
2/25/20267.41 USD
2/24/20267.14 USD
2/23/20267.09 USD
2/20/20267.15 USD
2/19/20267.19 USD
2/18/20267.13 USD
2/17/20267.04 USD
2/13/20267.03 USD
2/12/20266.92 USD
2/11/20266.93 USD
2/10/20266.95 USD
2/9/20266.81 USD
2/6/20266.83 USD
2/5/20266.54 USD
2/4/20266.93 USD
2/3/20267.11 USD
2/2/20267.18 USD
1/30/20267.07 USD
1/29/20267.07 USD
1/28/20267.10 USD
1/27/20267.10 USD
1/26/20267.31 USD
1/23/20267.34 USD
1/22/20267.37 USD
1/21/20267.21 USD
1/20/20267.18 USD
1/16/20267.25 USD
1/15/20267.44 USD
1/14/20267.25 USD
1/13/20267.25 USD
1/12/20267.46 USD
1/9/20267.40 USD
1/8/20267.38 USD
1/7/20267.30 USD
1/6/20267.28 USD
1/5/20267.05 USD
1/2/20266.96 USD
12/31/20257.04 USD
12/30/20257.13 USD
12/29/20257.12 USD
12/26/20257.13 USD
12/24/20257.09 USD
12/23/20257.06 USD
12/22/20257.05 USD
12/19/20257.05 USD
12/18/20256.94 USD
12/17/20256.91 USD
12/16/20256.88 USD
12/15/20256.92 USD
12/12/20256.91 USD
12/11/20256.76 USD
12/10/20256.75 USD
12/9/20256.48 USD
12/8/20256.41 USD
12/5/20256.48 USD
12/4/20256.46 USD
12/3/20256.40 USD
12/2/20256.30 USD
12/1/20256.41 USD
11/28/20256.50 USD
11/26/20256.56 USD
11/25/20256.63 USD
11/24/20256.49 USD
11/21/20256.44 USD
11/20/20256.18 USD
11/19/20256.18 USD
11/18/20256.20 USD
11/17/20256.25 USD
11/14/20256.40 USD
11/13/20256.31 USD
11/12/20256.44 USD
11/11/20256.47 USD
11/10/20256.43 USD
11/7/20256.29 USD
11/6/20256.25 USD
11/5/20254.81 USD
11/4/20254.98 USD
11/3/20254.92 USD
10/31/20254.90 USD
10/30/20254.91 USD
10/29/20254.98 USD
10/28/20255.10 USD
10/27/20255.11 USD
10/24/20255.20 USD
10/23/20255.14 USD
10/22/20255.11 USD
10/21/20255.20 USD
10/20/20255.16 USD
10/17/20255.04 USD
10/16/20255.04 USD
10/15/20255.19 USD
10/14/20255.09 USD
10/13/20255.11 USD
10/10/20255.05 USD
10/9/20255.36 USD
10/8/20255.64 USD
10/7/20255.53 USD
10/6/20255.61 USD
10/3/20255.51 USD
10/2/20255.35 USD
10/1/20255.45 USD
9/30/20255.50 USD
9/29/20255.42 USD
9/26/20255.42 USD
9/25/20255.26 USD
9/24/20255.41 USD
9/23/20255.35 USD
9/22/20255.38 USD
9/19/20255.23 USD
9/18/20255.37 USD
9/17/20255.15 USD
9/16/20255.23 USD
9/15/20255.18 USD
9/12/20255.23 USD
9/11/20255.34 USD
9/10/20255.17 USD
9/9/20255.49 USD
9/8/20255.61 USD
9/5/20255.37 USD
9/4/20255.47 USD
9/3/20255.49 USD
9/2/20255.63 USD
8/29/20255.48 USD
8/28/20255.48 USD
8/27/20255.49 USD
8/26/20255.40 USD
8/25/20255.39 USD
8/22/20255.55 USD
8/21/20255.50 USD
8/20/20255.35 USD
8/19/20255.35 USD
8/18/20255.41 USD
8/15/20255.44 USD
8/14/20255.58 USD
8/13/20255.17 USD
8/12/20254.66 USD
8/11/20254.57 USD
8/8/20254.37 USD
8/7/20253.86 USD
8/6/20253.90 USD
Access this data via the Eulerpool API
Get Free API Key

LifeStance Health Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
667.51 M USD
-294.19 M USD
-307.20 M USD
Jan 1, 2022
859.54 M USD
-212.80 M USD
-215.56 M USD
Jan 1, 2023
1.06 B USD
-185.73 M USD
-186.26 M USD
Jan 1, 2024
1.25 B USD
-31.08 M USD
-57.44 M USD
Jan 1, 2025
1.42 B USD
24.15 M USD
9.66 M USD
Jan 1, 2026 (e)
1.66 B USD
652.38 M USD
53.22 M USD
Jan 1, 2027 (e)
1.90 B USD
745.45 M USD
79.39 M USD
Jan 1, 2028 (e)
2.18 B USD
854.99 M USD
150.49 M USD

LifeStance Health Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 6, 2026, 1:23 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
20192020202120222023202420252026e2027e2028e
0.210.380.670.861.061.251.421.661.902.18
–77.8376.9228.7922.8218.4813.9216.8514.2414.73
29.2535.5430.1327.5928.6332.1632.3732.3732.3732.37
62.00134.00201.00237.00302.00402.00461.00538.70615.42706.07
13.0015.00-294.00-212.00-185.00-31.0024.00652.00745.00854.00
6.133.98-44.08-24.68-17.54-2.481.6939.1839.1939.16
5.00-38.00-307.00-215.00-186.00-57.009.0053.0079.00150.00
–-860.00707.89-29.97-13.49-69.35-115.79488.8949.0689.87
393.11306.94339.19356.40371.89379.75393.11393.11393.11393.11
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales LifeStance Health Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue LifeStance Health Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare LifeStance Health Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares LifeStance Health Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against LifeStance Health Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

LifeStance Health Group stock margins

The LifeStance Health Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of LifeStance Health Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for LifeStance Health Group.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
30.19 %
-44.07 %
-46.02 %
Jan 1, 2022
27.57 %
-24.76 %
-25.08 %
Jan 1, 2023
28.62 %
-17.59 %
-17.64 %
Jan 1, 2024
32.17 %
-2.48 %
-4.59 %
Jan 1, 2025
32.37 %
1.70 %
0.68 %
Jan 1, 2026 (e)
32.37 %
39.20 %
3.20 %
Jan 1, 2027 (e)
32.37 %
39.20 %
4.17 %
Jan 1, 2028 (e)
32.37 %
39.20 %
6.90 %

LifeStance Health Group Stock Revenue, EBIT, Earnings per Share

The LifeStance Health Group earnings per share therefore indicates how much revenue LifeStance Health Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
1.97 USD
-0.87 USD
-0.91 USD
Jan 1, 2022
2.41 USD
-0.60 USD
-0.60 USD
Jan 1, 2023
2.84 USD
-0.50 USD
-0.50 USD
Jan 1, 2024
3.29 USD
-0.08 USD
-0.15 USD
Jan 1, 2025
3.62 USD
0.06 USD
0.02 USD
Jan 1, 2026 (e)
4.26 USD
1.66 USD
0.14 USD
Jan 1, 2027 (e)
4.86 USD
1.90 USD
0.20 USD
Jan 1, 2028 (e)
5.58 USD
2.17 USD
0.38 USD

LifeStance Health Group business model & stock analysis

Lifestance Health Group Inc is a leading company in the psychological health industry in the USA. The company was founded in 2017 and has its headquarters in New York City. Lifestance Health Group Inc offers a wide range of psychological health services, including diagnosis, treatment, and care for all types of mental disorders. The company is divided into various divisions, including Lifestance Health Group, MindPath Care Centers, and Greenbrook TMS. All of these divisions offer different offerings tailored to the specific needs of their customers. Lifestance Health Group is a network of professionals specializing in the treatment of mental illnesses. The network includes over 2,500 licensed professionals, including psychiatrists, psychologists, social workers, and therapists. The network treats people with various mental illnesses, including depression, anxiety disorders, bipolar disorder, post-traumatic stress disorder (PTSD), and eating disorders. MindPath Care Centers is a specialized company that focuses on the treatment of anxiety disorders, depression, and other mental disorders. MindPath Care Centers specializes in providing solutions for individuals with different needs, including telemedicine online therapy. MindPath Care Centers also provides comprehensive training for insurance companies and employers to create a sensitized work environment and achieve higher employee satisfaction than expected. Greenbrook TMS (Transcranial Magnetic Stimulation) specializes in extracurricular stimulation. This is a non-invasive procedure for the treatment of depression aimed at patients who do not respond to medication or who suffer from severe side effects. By using the latest technologies, Greenbrook TMS helps patients who want to alleviate their depressive symptoms to regain their quality of life and workability. The business model of Lifestance Health Group Inc is focused on providing first-class and affordable services in the psychological health industry. The company strives for consistently high quality in all aspects of its business and offers its customers a comprehensive range of services to optimize their care. Lifestance Health Group Inc also offers an extensive training program aimed at providing professionals, insurance companies, and employers with the knowledge and skills to better treat and manage mental illnesses. Overall, Lifestance Health Group Inc is an innovative company that plays an important role in the field of psychological health care in the USA through its versatility and dedicated professionals. With a strong business model and a comprehensive range of services, the company offers its customers a wide range of opportunities to improve their mental health and quality of life.

LifeStance Health Group SWOT Analysis

Strengths

Lifestance Health Group Inc possesses several significant strengths which contribute to its success and competitiveness in the industry. These strengths include:

  • Strong financial position, allowing for investments in technology, growth, and acquisitions.
  • Wide range of services offered, catering to diverse mental health needs of patients.
  • Established reputation and brand recognition, leading to customer loyalty.
  • Strategic partnerships with healthcare providers, enabling better access to patients.
  • Experienced and skilled team of professionals, ensuring high-quality care.

Weaknesses

Despite its strengths, Lifestance Health Group Inc also faces certain weaknesses which need to be addressed to maintain its competitive edge. These weaknesses include:

  • Relatively limited market presence compared to larger competitors.
  • Dependency on key personnel, which poses succession planning challenges.
  • Slow adoption of digital technologies compared to industry peers.
  • High operating costs due to extensive clinical support services.
  • Limited geographic reach, mainly focused on specific regions.

Opportunities

Lifestance Health Group Inc can capitalize on various opportunities in the market to drive growth and expansion. These opportunities include:

  • Increasing demand for mental health services due to rising awareness and societal changes.
  • Expansion into untapped markets or underserved areas.
  • Development of telehealth platforms to reach a wider patient base.
  • Acquisition or partnership with complementary businesses to broaden service offerings.
  • Exploring international markets to diversify revenue streams.

Threats

Lifestance Health Group Inc should be aware of potential threats in the external environment that could impact its operations and growth. These threats include:

  • Increasing competition from both established and emerging players in the mental health industry.
  • Changes in government regulations and reimbursement policies affecting healthcare providers.
  • Economic downturns leading to reduced healthcare spending.
  • Public perception and stigma surrounding mental health issues.
  • Technological advancements disrupting traditional healthcare delivery models.

LifeStance Health Group Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

LifeStance Health Group Employees
Details
Date
LifeStance Health Group Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

LifeStance Health Group Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

LifeStance Health Group historical P/E ratio, EBIT multiple, and P/S ratio

LifeStance Health Group annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

LifeStance Health Group shares outstanding

The number of shares of LifeStance Health Group was 393.11 M in 2025. This indicates how many shares LifeStance Health Group is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
339.19 M Stocks
Jan 1, 2022
356.40 M Stocks
Jan 1, 2023
371.89 M Stocks
Jan 1, 2024
379.75 M Stocks
Jan 1, 2025
393.11 M Stocks
Jan 1, 2026 (e)
393.11 M Stocks
Jan 1, 2027 (e)
393.11 M Stocks
Jan 1, 2028 (e)
393.11 M Stocks

Current LifeStance Health Group forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
82.35 % (14)
Hold
17.65 % (3)
Sell
0.00 % (0)
12M Price Target
8.67
Last Price
10.35
Currency
USD
12M Return Potential
-16.27 %
LTM Return
0 %

LifeStance Health Group Analyst Rating Actions

DateFirmActionRatingReliability
7/24/2026
BTIG
BTIG
MaintainedBuy–
7/21/2026
Canaccord Genuity
Canaccord Genuity
MaintainedBuy59
7/14/2026
Barclays
Barclays
MaintainedOverweight33
7/13/2026
Keybanc
Keybanc
MaintainedOverweight49
6/5/2026
Goldman Sachs
Goldman Sachs
DowngradeBuyNeutral–
5/14/2026
JP Morgan
JP Morgan
MaintainedNeutral80
5/8/2026
BTIG
BTIG
MaintainedBuy–
3/6/2026
Barclays
Barclays
MaintainedOverweight33
2/26/2026
UBS
UBS
MaintainedBuy51
2/26/2026
Keybanc
Keybanc
MaintainedOverweight49

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

LifeStance Health Group Earnings Calls

2025

LifeStance Health Group Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/6/20260.04USD-422.66 MUSD-2026 Q2
5/7/20260.01USD-395.11 MUSD-2026 Q1
2/25/2026-0.00USD-383.83 MUSD-2025 Q4
11/8/2022-0.14USD-222.94 MUSD-2022 Q3

EESG©

Eulerpool ESG Scorecard© for the LifeStance Health Group stock

24/100
26
Environment
24
Social
21
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

LifeStance Health Group shareholder structure

% Name
41.08842%
TPG Capital, L.P.
TPG Capital, L.P.
35.79997%
TPG GP A, LLC
TPG GP A, LLC
15.00386%
FMR LLC
FMR LLC
10.12465%
Fidelity Management & Research Company LLC
Fidelity Management & Research Company LLC
8.57111%
Summit Partners, L.P.
Summit Partners, L.P.
7.46793%
SUMMIT PARTNERS L P
SUMMIT PARTNERS L P
...

LifeStance Health Group Beneficial Ownership Filings (SEC 13D/G)

Free Float
52.4%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
46.80%
Jon Winkelried
Jon Winkelried
SEC ↗
46.80%
James G. Coulter
James G. Coulter
SEC ↗
46.80%
David Bonderman
David Bonderman
SEC ↗
29.30%
TPG GP A, LLC
TPG GP A, LLC
SEC ↗
15.00%
FMR LLC
FMR LLC
SEC ↗
12.22%
2.
2.
SEC ↗
8.30%
BlackRock, Inc.
BlackRock, Inc.
SEC ↗
7.49%
Summit Partners, L.P.
Summit Partners, L.P.
SEC ↗
5.60%
Michael K. Lester
Michael K. Lester
SEC ↗
5.20%
Silversmith Partners I GP, L.P.
Silversmith Partners I GP, L.P.
SEC ↗

LifeStance Health Group Executives and Management Board

15 members · avg. age 52 · 33 % women

DB

Mr. David Bourdon (56)

Chief Executive Officer, Executive Director · since 2022

3.45 M USD

Management

RP

Mr. Ryan Pardo (49)

Chief Legal Officer, Secretary

2.61 M USD
AV

Ms. Ann Varanakis (47)

Chief People Officer

1.67 M USD
RM

Mr. Ryan Mcgroarty (52)

Chief Financial Officer, Treasurer

–
LM

Ms. Lisa Miller (51)

Executive Vice President of Practice Operations

–
UR

Dr. Ujjwal Ramtekkar (43)

Chief Medical Officer

–
MP

Ms. Monica Prokocki

Vice President - Finance and Investor Relations · since 2022

–

Board of Directors

KB

Mr. Kenneth Burdick (66)

Executive Chairman of the Board · since 2022

10.20 M USD
TD

Dr. Teresa Deluca (59)

Independent Director

440,654.00 USD
ES

Mr. Eric Shuey (57)

Independent Director

269,997.00 USD
RB

Dr. Robert Bessler (53)

Independent Director

249,997.00 USD
SP

Mr. Sarah Personette

Director

–
DB

Mr. Darren Black (53)

Independent Director

–

Frequently asked questions about LifeStance Health Group

Lifestance Health Group Inc is a leading healthcare organization specializing in providing comprehensive mental health services. Their business model encompasses the integration of psychiatrists, clinical psychologists, therapists, and psychiatric nurse practitioners to offer personalized and evidence-based treatment to individuals of all ages. By combining a multidisciplinary approach with innovative technologies, Lifestance Health Group Inc aims to deliver high-quality and accessible mental healthcare across their network of clinics. With a focus on patient-centric care and a commitment to improving mental wellness, Lifestance Health Group Inc has become a trusted provider in the industry, striving to make a positive impact on individuals' lives.

Lifestance Health Group Inc is primarily active in the healthcare industry.

The main competitors of Lifestance Health Group Inc in the market include companies such as Acadia Healthcare Company Inc, Universal Health Services Inc, and HCA Healthcare Inc.

Lifestance Health Group Inc is a leading provider of mental health services in the United States. Founded in 2005, the company has a rich history of offering comprehensive and personalized care to individuals struggling with mental health conditions. Lifestance Health Group Inc has established itself as a trusted name in the industry by combining evidence-based practices with a patient-centered approach. With a team of experienced and compassionate clinicians, the company offers a wide range of services, including therapy, medication management, and telepsychiatry. Lifestance Health Group Inc continues to grow and expand its reach to help improve the lives of individuals facing mental health challenges.

Lifestance Health Group Inc has achieved several significant milestones in its journey. The company has successfully expanded its network, establishing a strong presence across multiple states in the United States. Lifestance Health Group Inc has also developed a reputation for excellence in its specialized behavioral health services, offering comprehensive care to patients. The company has consistently grown its patient base, delivering high-quality care and demonstrating exceptional clinical outcomes. Lifestance Health Group Inc has continually focused on innovation, leveraging technology to improve patient experience and streamline operations. Overall, Lifestance Health Group Inc has exhibited impressive growth and success in the behavioral health industry, solidifying its position as a leading provider.

Lifestance Health Group Inc is primarily present in the United States.

Lifestance Health Group Inc represents a strong commitment to providing high-quality mental health care services. The company prides itself on its patient-centered approach, putting individuals at the forefront of their treatment plans. Lifestance Health Group Inc believes in promoting the overall well-being of their patients by offering personalized and evidence-based treatment options. The company's corporate philosophy revolves around creating a supportive and compassionate environment, fostering growth and resilience for their patients. By emphasizing collaboration and innovation, Lifestance Health Group Inc ensures that individuals receive comprehensive care that addresses their unique needs.

Analysts currently set an average price target of 9.07 USD for the LifeStance Health Group stock (median: 8.67 USD), implying -12.4 % versus the latest price. The consensus is based on 17 analyst ratings.

LifeStance Health Group Analyst Price Targets 2026

17 analysts currently rate the LifeStance Health Group stock: 14 recommend buying, 3 holding and 0 selling. For 2026, analysts expect LifeStance Health Group to generate revenue of 1.66 B USD and earnings per share of 0.14 USD.

LifeStance Health Group Analyst Price Targets 2026

Converted at the current exchange rate, the LifeStance Health Group share trades at 9.09 EUR (10.48 USD).

The LifeStance Health Group share (LFST) is listed on 1 stock exchanges, including: NASDAQ (LFST).

Lifestance Health Group Inc is a leading provider of behavioral health services in the United States. The company was founded to make mental health services more accessible to a wider audience by developing innovative solutions tailored to the individual needs and requirements of each patient. Lifestance Health Group offers holistic mental health services provided by experienced and qualified professionals. These services include psychological counseling, psychotherapy, psychiatry, neuropsychology, and clinical social work. The company also offers telehealth services that allow customers to virtually connect with their healthcare providers, as well as specialized programs for children, adolescents, and families. The company operates in three main segments: Clinic Segment, Telehealth Services, and Specialized Programs. In summary, Lifestance Health Group offers a comprehensive portfolio of mental health services tailored to the specific needs and requirements of each patient. The company is committed to developing innovative solutions to facilitate access to mental health services and improve people's quality of life.

The expected revenue of LifeStance Health Group is 1.66 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of LifeStance Health Group is 53.22 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of LifeStance Health Group is currently 77.41. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the LifeStance Health Group stock.

The price-to-sales ratio (P/S) of LifeStance Health Group is currently 2.48. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the LifeStance Health Group stock.

The Eulerpool Quality Score for LifeStance Health Group is 4/10.

The ISIN of LifeStance Health Group is US53228F1012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of LifeStance Health Group is LFST. The ticker symbol is used to trade LifeStance Health Group shares on the stock exchange.

LifeStance Health Group paid dividends every year for the past 0 years.

LifeStance Health Group is assigned to the 'Health' sector.

The dividends of LifeStance Health Group are distributed in USD.

All fundamentals and in-depth analysis of LifeStance Health Group

Our stock analysis for LifeStance Health Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LifeStance Health Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

LifeStance Health Group Stock
LifeStance Health Group Revenue→
LifeStance Health Group Stock
LifeStance Health Group Net Income→
LifeStance Health Group Stock
LifeStance Health Group P/E→
LifeStance Health Group Stock
LifeStance Health Group P/S→
LifeStance Health Group Stock
LifeStance Health Group EBIT→
LifeStance Health Group Stock
LifeStance Health Group Dividend→
LifeStance Health Group Stock
LifeStance Health Group Directors Dealings→
LifeStance Health Group Stock
LifeStance Health Group Stocks→
LifeStance Health Group Stock
LifeStance Health Group Market capitalization→
LifeStance Health Group Stock
LifeStance Health Group Debt→
LifeStance Health Group Stock
LifeStance Health Group Liabilities→
LifeStance Health Group Stock
LifeStance Health Group Equity→
LifeStance Health Group Stock
LifeStance Health Group AAQS→
LifeStance Health Group Stock
LifeStance Health Group Employees→
LifeStance Health Group Stock
LifeStance Health Group ROE→
LifeStance Health Group Stock
LifeStance Health Group ROA→
LifeStance Health Group Stock
LifeStance Health Group ROCE→
LifeStance Health Group Stock
LifeStance Health Group News→
LifeStance Health Group Stock
LifeStance Health Group Analyst Price Targets→

Health Stocks

LifeTech ScientificLifecome Biochemistry CoLifewardLifecare ALigaChem BiosciencesLife Healthcare Group HoldingsLigand PharmaceuticalsLiaoning He Eye Hospital Group CoLiguaLiaoning Chengda Biotechnology CoLimes SchlossklinikenLexicon PharmaceuticalsAll Stocks A–Z →